NO donor-activated PKC-δ plays a pivotal role in ischemic myocardial protection through accelerated opening of mitochondrial K-ATP channels

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 1, 2004, Pages 35-41

  Harada, Nozomu ^a   Miura, Toshiro ^a   Dairaku, Yuka ^a   Kametani, Ryosuke ^a   Shibuya, Masaki ^a   Wang, Ruijuan ^a   Kawamura, Shuji ^a   Matsuzaki, Masunori ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Mitochondrial K ATP channel; Nitric oxide; Protein kinase C

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; CHELERYTHRINE; DIAZOXIDE; NICORANDIL; NITRIC OXIDE; NITRIC OXIDE DONOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOBLOTTING; ISOLATED HEART; MITOCHONDRIAL ATP SENSITIVE POTASSIUM CHANNEL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DIAZOXIDE; ENZYME ACTIVATION; HEART RATE; ISOENZYMES; MEMBRANE PROTEINS; MYOCARDIAL ISCHEMIA; NICORANDIL; NITRIC OXIDE; POTASSIUM CHANNELS; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3042703980     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200407000-00005     Document Type: Article

References (29)

1. Liu Y, Sato T, O'Rourke B, et al. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation. 1998;97:2463-2469.
2. + channels. Circ Res. 1997;81:1072-1082.
3. Auchampach JA, Grover GJ, Gross GJ. Blockade of ischemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992;26:1054-1062.
4. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J-24J.
5. IONA Study group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet. 2002;359:1269-1275.
6. Sato T, Sasaki N, O'Rourke B, et al. Nicorandil, a potent cardioprotective agents, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-518.
7. Yoshida K, Mizukami Y, Kitakaze M. Nitric oxide mediates protein kinase C isoform translocation in rat heart during postischemic reperfusion. Biochim Biophys Acta. 1999;1453:230-238.
8. Nakano A, Liu GS, Heusch G, et al. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol. 2000;32:1159-1167.
9. + channels by protein kinase C. Circ Res. 1998;83:110-114.
10. ATP channel openers on chronic left ventricular remodeling in the ischemic-reperfused rat heart. Circ J. 2002;66:411-415.
11. Kawamura S, Mizukami Y, Miura T, et al. Ischemic preconditioning translocates PKC-δ and -ε, which mediate functional protection in isolated rat heart. Am J Physiol Heart Circ Physiol. 1998;275:H2266-H2271.
12. Kraft AS, Anderson WB. Phorbol ester increase the amount of Ca, phospholipid-dependent protein kinase associated with plasma membrane. Nature. 1983;301:621-623.
13. Liu Y, Ytrehus K, Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol. 1994;26:661-668.
14. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Circ Res. 1994;75:586-590.
15. Mitchell MB, Meng X, Ao L, et al. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
16. Sugden PH, Bogoyevitch MA. Intracellular signaling through protein kinases in the heart. Cardiovasc Res. 1995;30:478-492.
17. Wetsel WC, Khan WA, Merchenthaler I, et al. Tissue and cellular distribution of extended family of protein kinase C isoenzymes. J Cell Biol. 1992;117:121-133.
18. Zhao J, Renner O, Wightman L, et al. The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem. 1998;273:23072-23079.
19. Gray MO, Karliner JS, Mochly-Rosen D. A selective protein kinase C-δ antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem. 1997;272:30945-30951.
20. + channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circ Res. 1999;85:731-741.
21. ATP channel occurs downstream of PKC-δ activation in the mechanism of preconditioning. Am J Physiol Heart Circ Physiol. 2002;283:H440-H447.
22. Inagaki K, Hahn HS, Dorn GW, et al. Additive protection of the ischemic heart ex vivo by combined treatment with δ-protein kinase C inhibitor and ε-protein kinase C activator. Circulation. 2003;108:869-875.
23. Matsumoto T, Takahashi M, Omura T, et al. Heterogeneity in the vasorelaxing effect of nicorandil on dog epicardial coronary arteries: Comparison with other NO donors. J Cardiovasc Pharmacol. 1997;29:772-779.
24. Ping P, Takano H, Zhang J, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits. A signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res. 1999;84:587-604.
25. 1 receptor mediates late preconditioning via activation of PKC-delta signaling pathway. Am J Physiol Heart Circ Physiol. 2002;283:H296-H301.
26. Lochner A, Marais E, Genade S, et al. Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol. 2000;279:H2752-H2765.
27. Rakhit RD, Edwards RJ, Marber MS. Nitric oxide, nitrates and ischaemic preconditioning. Cardiovasc Res. 1999;43:621-627.
28. Mochly-Rosen D, Khaner H, Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci U S A. 1991;88:3997-4000.
29. Balafanova Z, Bolli R, Zhang J, et al. Nitric oxide (NO) induces nitration of protein kinase Cε(PKCε), facilitating PKCε translocation via enhanced PKCε-RACK2 interactions. J Biol Chem. 2002;277:15021-15027.